Parkinson's Disease Trial, Recruiting NCT07216976 Sponsor: MedtronicNeuro Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07216976
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Parkinson's disease that developed without a known cause (called "idiopathic" Parkinson's disease)
  • You already have a specific Medtronic brain stimulation device (Percept PC or Percept RC) implanted, along with specific matching leads and connectors placed on both sides of the brain in the same target area — and the device has been in place for more than 3 months (or more than 1 month if the device was recently replaced)
  • Your doctor believes your brain stimulation therapy is helping your Parkinson's symptoms
  • Your brain stimulation settings and Parkinson's medications have been stable for at least the last 4 weeks, and are expected to stay stable throughout the study
  • Your device is set up in a specific way on at least one side of the brain (using certain electrical contact points — confirm with trial site)
  • You are willing and able to attend all required study visits and complete all study tasks, such as memory questionnaires and movement assessments
  • You (or your legal representative) can understand and sign a written consent form before the study begins
  • You are male, or a female who is not pregnant — if you are a woman who could become pregnant and are sexually active, you must be using or agree to use an acceptable form of birth control
  • A brain signal test shows that your implanted device can detect a specific type of brain wave activity (in the 8–30 Hz range) at a certain strength level (confirm with trial site)

Who may not be able to join:

  • You or your caregiver are unable to use the handheld patient device that controls the brain stimulator
  • You have more than one stimulation lead placed in either side of your brain
  • You have any additional brain implants, such as leads placed on the surface of the brain, or other unapproved devices in the brain
  • You have more than one implanted stimulator device
  • Your implanted device's battery is expected to run out within less than one year
  • You score above 25 on a standard depression questionnaire called the Beck Depression Inventory II (confirm with trial site)
  • You need, or are likely to need, certain medical treatments including deep heat therapy (diathermy), transcranial magnetic stimulation (TMS), or electroconvulsive therapy (ECT)
  • You have a metal implant in your head, such as an aneurysm clip or cochlear implant
  • You have, or plan to get, any other implanted electrical medical device in your body, such as a heart pacemaker, defibrillator, or spinal cord stimulator
  • You have, or plan to get, an implanted or portable medication pump used to treat Parkinson's disease
  • In your doctor's opinion, your neurological examination results would prevent you from safely taking part in the study
  • You are currently breastfeeding
  • You are under 18 years of age
  • You are currently enrolled in, or plan to join, another drug or device study that could affect the results of this trial
  • The brain signal readings from your device show interference on all possible measurement pathways, making it impossible to set the device thresholds needed for the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alex Xie, Clinical Research&Medical Science Director, Medtronic (Shanghai) Management Co. Ltd.

Phone: +86 18612318110

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
MedtronicNeuro
Registry
ClinicalTrials.gov
Start date
19 November 2025
Est. completion
1 January 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

"On" time without troublesome dyskinesia (i.e. Good "On" Time)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov